HRTX EBITDA Margin
Heron Therapeutics Inc · EBITDA Margin
HRTX EBITDA Margin
Latest reported-18.53%period ending
HRTX EBITDA Margin (-188.24% → -18.53%)
Annual ebitda margin
High-resolution chart · PNG
HRTX ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -11.5433% | |
| -3.5042% | |
| -81.6977% | |
| -164.0733% | |
| -249.2901% | |
| -251.0549% | |
| -137.861% | |
| -225.4369% | |
| -624.0972% | |
| -13,243.1587% | |
| 0% | |
| 0% | |
| 0% | |
| -3,689.0093% | |
| -1,684.6749% | |
| -535.5111% | |
| -783.981% | |
| -6,242.0054% | |
| -5,666.0194% | |
| 109.6457% | |
| -148.8963% | |
| -160.7328% | |
| -122.9167% | |
| -78.7962% | |
| -154.2968% | |
| -119.8455% | |
| -7.3529% | |
| -10% | |
| -4.6512% | |
| -37.9679% | |
| -45.9627% | |
| -49.6855% | |
| -46.2312% | |
| -72.6027% | |
| -114.2857% | |
| -162.5% | |
| -164.2857% | |
| -200% | |
| -188.2353% |